178 related articles for article (PubMed ID: 34579929)
21. Polyethylene glycol-modified gelatin/polylactic acid nanoparticles for enhanced photodynamic efficacy of a hypocrellin derivative in vitro.
Babu A; Periasamy J; Gunasekaran A; Kumaresan G; Naicker S; Gunasekaran P; Murugesan R
J Biomed Nanotechnol; 2013 Feb; 9(2):177-92. PubMed ID: 23627044
[TBL] [Abstract][Full Text] [Related]
22. Selective photodynamic effects on cervical cancer cells provided by P123 Pluronic®-based nanoparticles modulating hypericin delivery.
Damke GMZF; Damke E; de Souza Bonfim-Mendonça P; Ratti BA; de Freitas Meirelles LE; da Silva VRS; Gonçalves RS; César GB; de Oliveira Silva S; Caetano W; Hioka N; Souza RP; Consolaro MEL
Life Sci; 2020 Aug; 255():117858. PubMed ID: 32497635
[TBL] [Abstract][Full Text] [Related]
23. Hypericin-photodynamic therapy leads to interleukin-6 secretion by HepG2 cells and their apoptosis via recruitment of BH3 interacting-domain death agonist and caspases.
Barathan M; Mariappan V; Shankar EM; Abdullah BJ; Goh KL; Vadivelu J
Cell Death Dis; 2013 Jun; 4(6):e697. PubMed ID: 23807226
[TBL] [Abstract][Full Text] [Related]
24. Exploring Modes of Photokilling by Hypericin.
Kessel D
Photochem Photobiol; 2020 Sep; 96(5):1101-1104. PubMed ID: 32343412
[TBL] [Abstract][Full Text] [Related]
25. Hypericin-photodynamic therapy inhibits the growth of adult T-cell leukemia cells through induction of apoptosis and suppression of viral transcription.
Xu L; Zhang X; Cheng W; Wang Y; Yi K; Wang Z; Zhang Y; Shao L; Zhao T
Retrovirology; 2019 Feb; 16(1):5. PubMed ID: 30782173
[TBL] [Abstract][Full Text] [Related]
26. In vitro fungicidal photodynamic effect of hypericin on Candida species.
Rezusta A; López-Chicón P; Paz-Cristobal MP; Alemany-Ribes M; Royo-Díez D; Agut M; Semino C; Nonell S; Revillo MJ; Aspiroz C; Gilaberte Y
Photochem Photobiol; 2012; 88(3):613-9. PubMed ID: 22128758
[TBL] [Abstract][Full Text] [Related]
27. Hypericin and its radio iodinated derivatives - A novel combined approach for the treatment of pediatric alveolar rhabdomyosarcoma cells in vitro.
Ocker L; Adamus A; Hempfling L; Wagner B; Vahdad R; Verburg FA; Luster M; Schurrat T; Bier D; Frank M; Lisec J; Engel N; Seitz G
Photodiagnosis Photodyn Ther; 2020 Mar; 29():101588. PubMed ID: 31704507
[TBL] [Abstract][Full Text] [Related]
28. Cellular mechanisms and prospective applications of hypericin in photodynamic therapy.
Kiesslich T; Krammer B; Plaetzer K
Curr Med Chem; 2006; 13(18):2189-204. PubMed ID: 16918348
[TBL] [Abstract][Full Text] [Related]
29. Potentiation of hypericin-mediated photodynamic therapy cytotoxicity by MK-886: focus on ABC transporters, GDF-15 and redox status.
Kuchárová B; Mikeš J; Jendželovský R; Vargová J; Mikešová L; Jendželovská Z; Kovaľ J; Fedoročko P
Photodiagnosis Photodyn Ther; 2015 Sep; 12(3):490-503. PubMed ID: 26003114
[TBL] [Abstract][Full Text] [Related]
30. Antibiotic-free nanotherapeutics: hypericin nanoparticles thereof for improved in vitro and in vivo antimicrobial photodynamic therapy and wound healing.
Nafee N; Youssef A; El-Gowelli H; Asem H; Kandil S
Int J Pharm; 2013 Sep; 454(1):249-58. PubMed ID: 23834835
[TBL] [Abstract][Full Text] [Related]
31. Effective transport of aggregated hypericin encapsulated in SBA-15 nanoporous silica particles for photodynamic therapy of cancer cells.
Pevná V; Zauška Ľ; Benziane A; Vámosi G; Girman V; Miklóšová M; Zeleňák V; Huntošová V; Almáši M
J Photochem Photobiol B; 2023 Oct; 247():112785. PubMed ID: 37714000
[TBL] [Abstract][Full Text] [Related]
32. Differential susceptibility of primary cultured human skin cells to hypericin PDT in an in vitro model.
Popovic A; Wiggins T; Davids LM
J Photochem Photobiol B; 2015 Aug; 149():249-56. PubMed ID: 26114219
[TBL] [Abstract][Full Text] [Related]
33. Non-Polymeric Nanogels as Versatile Nanocarriers: Intracellular Transport of the Photosensitizers Rose Bengal and Hypericin for Photodynamic Therapy.
Torres-Martínez A; Bedrina B; Falomir E; Marín MJ; Angulo-Pachón CA; Galindo F; Miravet JF
ACS Appl Bio Mater; 2021 Apr; 4(4):3658-3669. PubMed ID: 35014451
[TBL] [Abstract][Full Text] [Related]
34. Hypericin-P123-photodynamic therapy in an ex vivo model as an alternative treatment approach for onychomycosis caused by Fusarium spp.
Conrado PCV; Sakita KM; Arita GS; Gonçalves RS; Cesar GB; Caetano W; Hioka N; Voidaleski MF; Vicente VA; Svidzinski TIE; Bonfim-Mendonça PS; Kioshima ES
Photodiagnosis Photodyn Ther; 2021 Sep; 35():102414. PubMed ID: 34186264
[TBL] [Abstract][Full Text] [Related]
35. Enhanced photodynamic activity of hypericin by penetration enhancer N-methyl pyrrolidone formulations in the chick chorioallantoic membrane model.
Saw CL; Heng PW; Chin WW; Soo KC; Olivo M
Cancer Lett; 2006 Jul; 238(1):104-10. PubMed ID: 16054752
[TBL] [Abstract][Full Text] [Related]
36. Conjunction of glutathione level, NAD(P)H/FAD redox status and hypericin content as a potential factor affecting colon cancer cell resistance to photodynamic therapy with hypericin.
Mikešová L; Mikeš J; Kovaľ J; Gyurászová K; Culka L; Vargová J; Valeková B; Fedoročko P
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):470-83. PubMed ID: 24284100
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of hypericin-loaded solid lipid nanoparticles: physicochemical properties, photostability and phototoxicity.
Youssef T; Fadel M; Fahmy R; Kassab K
Pharm Dev Technol; 2012; 17(2):177-86. PubMed ID: 21047275
[TBL] [Abstract][Full Text] [Related]
38. Hypericin photodynamic activity in DPPC liposomes - part II: stability and application in melanoma B16-F10 cancer cells.
de Morais FAP; Gonçalves RS; Vilsinski BH; Lazarin-Bidóia D; Balbinot RB; Tsubone TM; Brunaldi K; Nakamura CV; Hioka N; Caetano W
Photochem Photobiol Sci; 2020 May; 19(5):620-630. PubMed ID: 32248218
[TBL] [Abstract][Full Text] [Related]
39. Novel Insights into the Effect of Hyperforin and Photodynamic Therapy with Hypericin on Chosen Angiogenic Factors in Colorectal Micro-Tumors Created on Chorioallantoic Membrane.
Majerník M; Jendželovský R; Babinčák M; Košuth J; Ševc J; Tonelli Gombalová Z; Jendželovská Z; Buríková M; Fedoročko P
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31248208
[TBL] [Abstract][Full Text] [Related]
40. Hypericin-mediated photodynamic therapy inhibits growth of colorectal cancer cells via inducing S phase cell cycle arrest and apoptosis.
Hu J; Song J; Tang Z; Wei S; Chen L; Zhou R
Eur J Pharmacol; 2021 Jun; 900():174071. PubMed ID: 33811836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
